View all cases
UPC CFI 1849/2026
—·EP2077811: CLAY-BASED HEMOSTATIC AGENTS AND DEVICES FOR THE DELIVERY THEREOF
- Case details
- Status—ActionOtherCategoryOther Procedural
- Parties
- ClaimantsRepresentatives
- Ulrich Blumenröder-Grünecker Patent- und Rechtsanwälte PartGmbH
- Sebastian Ochs-Grünecker Patent- und Rechtsanwälte PartGmbH
- Elvira Bertram-Grünecker Patent- und Rechtsanwälte PartGmbH
- Thomas Laubenthal-Grünecker Patent- und Rechtsanwälte PartGmbH
- Alexander Stumvoll-Grünecker Patent- und Rechtsanwälte PartGmbH
RespondentsRepresentatives- Peter-Michael Weisse-Wildanger Kehrwald Graf von Schwerin & Partner mbB
- Alexander Reetz-Wildanger Kehrwald Graf von Schwerin & Partner mbB
- Eva-Maria Thörner-Wildanger Kehrwald Graf von Schwerin & Partner mbB
- Jan-Caspar Maiers-Wildanger Kehrwald Graf von Schwerin & Partner mbB
- Division
- Hamburg LD
- Judges
- Sabine Klepsch · rapporteur
- Technology
- Pharmaceutical & Medical
- Language
- —
- First decided
- Jul 9, 2026
Decisions
- 2026-07-09OtherPublic
Summary: The Local Division Hamburg issued a cost decision following the dismissal of the infringement action and revocation of EP 2 077 811 (claims 1, 2, 3, 7 and 9) in the underlying proceedings (UPC_CFI_685/2024 / UPC_CFI_157/2025). The Claimant was ordered to reimburse the Defendant's costs totalling EUR 211,000.00 (EUR 200,000.00 legal fees plus EUR 11,000.00 court fees), to be paid within three weeks of service.
Show the legal issues (3)
- cost allocation after dismissal of infringement action and patent revocation
- applicable ceiling for recoverable costs under the Scale of Ceilings for Recoverable Costs of the Administrative Committee
- reasonableness and proportionality of costs under R.151 RoP
Documents
- cost%20decisionsigned.pdf2026-07-09EN